Congenital heart defect screening — 4-chamber view, outflow tracts, and 3-vessel view
Congenital heart disease (CHD) is the most common class of major birth defect, affecting roughly 8 per 1,000 live births. Most cases occur in pregnancies with no identifiable risk factor, which is why a competently performed basic cardiac screen is part of every routine anatomy scan — but certain maternal, fetal, and family factors substantially raise pretest probability and warrant a dedicated fetal echocardiogram performed by a specialist.
Pregestational diabetes mellitus (type 1 or type 2) raises CHD risk 3–5 fold in a dose-dependent relationship with first-trimester glycemic control; hemoglobin A1c in the first trimester correlates directly with risk. Gestational diabetes carries a much smaller increment in risk and is not, by itself, an automatic indication.
Maternal autoimmune disease with anti-Ro/SSA or anti-La/SSB antibodies confers risk of fetal congenital heart block and warrants serial fetal echocardiography beginning around 16 weeks to detect early PR interval prolongation before complete block develops.
Teratogen exposures — lithium (Ebstein anomaly), retinoic acid, certain anticonvulsants (valproate), and maternal phenylketonuria with poor dietary control — are each independently associated with structural cardiac malformation and merit dedicated cardiac evaluation.
Pregestational diabetes with a first-trimester HbA1c above 10% carries a CHD risk approaching 20–25%, making tight periconceptional glycemic control one of the most effective primary prevention strategies available in maternal-fetal medicine.
A prior child with CHD raises recurrence risk to roughly 3% for one affected sibling and higher with two or more, compared with a background population risk near 0.8%. Parental CHD, particularly maternal CHD, confers an even higher transmission risk (up to ~6–10% depending on the parental lesion) because of shared genetic and epigenetic contributions.
An increased nuchal translucency (≥95th percentile, or ≥3.5mm) in the first trimester is one of the strongest independent predictors of CHD, even with a normal karyotype and normal detailed anatomy later — the mechanism is thought to relate to transient venous congestion and altered cardiac loading in early cardiogenesis.
Fetal arrhythmia, extracardiac structural anomalies, abnormal karyotype (trisomy 21, 18, 13; 22q11.2 deletion), monochorionic twinning (twin-twin transfusion), and an abnormal four-chamber view on the routine anatomy scan are all independent indications for referral.
Every routine second-trimester anatomy ultrasound should include, at minimum: situs assessment, a four-chamber view (confirming chamber symmetry, an intact septum, and normally positioned atrioventricular valves), and — per current guidelines — the outflow tracts and a 3-vessel/trachea view whenever technically feasible.
The four-chamber view alone historically detected only 40–60% of major CHD because many important lesions (transposition of the great arteries, tetralogy of Fallot, coarctation) can present with a grossly normal four-chamber view. Adding outflow tract and 3-vessel views substantially improves detection of conotruncal anomalies and is now standard of care.
An abnormal or technically limited basic screen — including a poor acoustic window from maternal body habitus, fetal position, or oligohydramnios — is itself sufficient indication for a dedicated fetal echocardiogram.
A complete fetal echocardiogram follows a reproducible sequential sweep from the fetal abdomen cephalad through the thorax, systematically documenting situs, venous connections, the four-chamber view, both outflow tracts, and the great vessel arrangement at the level of the trachea. Skipping any step risks missing a conotruncal anomaly that spares the basic four-chamber view.
The sweep begins with confirmation of fetal situs solitus: stomach and cardiac apex both leftward, using the fetal spine and left/right orientation as landmarks. Abnormal situs (situs inversus, ambiguous situs/heterotaxy) carries a markedly elevated rate of complex CHD and reroutes the entire diagnostic approach.
The four-chamber view is obtained in a true transverse plane through the thorax at the level of the atrioventricular valves. Key elements assessed: two atria of similar size divided by an intact atrial septum with the foramen ovale flap, two ventricles of similar size and comparable wall thickness divided by an intact interventricular septum, two atrioventricular valves opening freely with offset septal insertion (the tricuspid valve inserts slightly more apically than the mitral valve — the "offsetting" sign that confirms normal AV septation), and a cardiac axis of roughly 45° leftward of the midline.
Any chamber size discrepancy, septal dropout, single AV valve, or abnormal axis triggers a search for structural disease.
From the four-chamber view, the transducer is angled cephalad and rotated to trace the left ventricular outflow tract (LVOT): the aorta should arise from the left ventricle, cross in continuity with the interventricular septum (no septal malalignment), and be roughly similar in caliber to the pulmonary artery.
Further cephalad angulation demonstrates the right ventricular outflow tract (RVOT): the main pulmonary artery arises from the right ventricle and should cross the aorta at roughly a right angle (the normal "crossing" relationship of the great vessels) before bifurcating into branch pulmonary arteries and continuing as the ductus arteriosus.
Loss of the normal crossing relationship — the two great vessels running in parallel rather than crossing — is the hallmark finding of transposition of the great arteries and is one of the most important patterns to recognize, because the four-chamber view is frequently entirely normal in this lesion.
A single transverse plane through the fetal upper mediastinum, just cephalad to the four-chamber view, simultaneously displays the pulmonary artery, aorta, and superior vena cava (the 3-vessel view), and — angled slightly further cephalad — adds the trachea and aortic arch (the 3-vessel-trachea view).
This view efficiently screens for great vessel size discrepancy (a small aorta suggests coarctation or hypoplastic left heart; a small pulmonary artery suggests tetralogy of Fallot or pulmonary stenosis/atresia), abnormal vessel alignment, and arch sidedness (right aortic arch can accompany conotruncal anomalies or a vascular ring).
Because it captures multiple great-vessel relationships in one efficient plane, the 3-vessel-trachea view has become a cornerstone of modern screening protocols and substantially increases detection of conotruncal and arch anomalies beyond the four-chamber view alone.
Adding outflow tract and 3-vessel views to the four-chamber view raises prenatal detection of major CHD from roughly 40–60% to over 90% in expert hands — the single biggest improvement in fetal cardiac screening of the past two decades.
Each major CHD produces a recognizable deviation from the normal chamber symmetry, valve morphology, septal integrity, and great-vessel relationship. Systematic comparison against the expected normal pattern at each view allows the examiner to localize the lesion and anticipate its physiology before birth.
The four-chamber view shows a markedly asymmetric heart: a diminutive, often echogenic (endocardial fibroelastosis) left ventricle contrasted with a dilated right ventricle. The mitral valve may be atretic or severely stenotic, and the LVOT sweep demonstrates a diminutive or atretic aortic valve with a tiny ascending aorta that fills retrograde from the ductus arteriosus via collateral flow — visible as reversed flow on color Doppler in the transverse arch.
HLHS is uniformly duct-dependent for systemic circulation: after birth, closure of the ductus arteriosus without intervention is rapidly fatal. Prenatal diagnosis allows delivery at a cardiac center with immediate postnatal prostaglandin E1 infusion to maintain ductal patency until staged surgical palliation (Norwood procedure) or cardiac transplantation.
D-TGA: the four-chamber view is often entirely normal — the diagnostic finding is only visible in the outflow tract sweep, where the aorta arises anteriorly from the right ventricle and the pulmonary artery arises posteriorly from the left ventricle, producing two parallel great vessels instead of the normal crossing relationship. This creates two parallel circulations rather than one in series, and survival depends entirely on mixing through a patent foramen ovale, ductus arteriosus, or VSD.
Tetralogy of Fallot: the classic tetrad — a large malalignment VSD, an overriding aorta straddling the septum, right ventricular outflow tract/pulmonary stenosis, and secondary right ventricular hypertrophy — is best appreciated in the LVOT view, where the aortic root is seen overriding the septum, and the RVOT view, where the main pulmonary artery and branches appear small relative to the aorta.
Both TGA and severe TOF frequently present with a normal-appearing four-chamber view — the outflow tract and 3-vessel views are not optional add-ons but are required to detect the majority of conotruncal anomalies.
A complete AV septal defect (AV canal) shows a large central defect spanning both the atrial and ventricular septa at the crux of the heart, with a single common AV valve crossing the septum instead of separate mitral and tricuspid valves — the "offsetting" sign of normal AV septation is absent, and both AV valve leaflets appear to insert at the same level.
Complete AV canal defects are strongly associated with trisomy 21 (present in roughly 40–50% of AVSD cases), so identification should prompt discussion of diagnostic testing (amniocentesis or NIPT/karyotype confirmation) as well as a detailed search for additional extracardiac anomalies.
Physiologically, AV canal produces a large mixing lesion with both left-to-right shunting and common AV valve regurgitation, typically requiring surgical repair in the first year of life to prevent irreversible pulmonary vascular disease (Eisenmenger physiology).
A prenatal CHD diagnosis is only clinically valuable if it changes management. The central question for delivery planning is whether the lesion is duct-dependent (requiring prostaglandin E1 and immediate specialist availability) and whether the anticipated postnatal course requires early catheter or surgical intervention — both of which mandate delivery at, or immediate transfer to, a tertiary center with pediatric cardiology and cardiac surgery on site.
Lesions are broadly stratified by whether systemic or pulmonary blood flow depends on a patent ductus arteriosus. Duct-dependent systemic circulation (HLHS, critical coarctation, interrupted aortic arch) requires the ductus to remain open to perfuse the body; duct-dependent pulmonary circulation (pulmonary atresia, critical pulmonary stenosis, severe tetralogy of Fallot) requires the ductus to remain open to perfuse the lungs. TGA depends on adequate intercirculatory mixing rather than duct patency alone, though ductal and atrial-level shunting both contribute.
For any duct-dependent lesion, a continuous prostaglandin E1 (alprostadil) infusion must be available immediately after birth to prevent ductal closure and cardiovascular collapse — this is only reliably achievable with a pre-established plan and on-site neonatology/cardiology, not by emergency transfer after a hypoxic or acidotic newborn is recognized in a community nursery.
Prenatal diagnosis followed by planned delivery at a tertiary cardiac center reduces preoperative mortality and morbidity for duct-dependent CHD compared with postnatal diagnosis after discharge — the single largest modifiable outcome driver identified across fetal cardiology outcome studies.
Mode of delivery for isolated CHD is determined by standard obstetric indications — CHD alone is not an indication for cesarean delivery. Timing is typically full term (39 weeks) unless a specific cardiac indication (e.g., evolving hydrops, arrhythmia, or severe ductal constriction) prompts earlier delivery, balanced against the risks of iatrogenic prematurity.
Delivery should occur at, or with an immediate hand-off plan to, a center with 24/7 pediatric cardiology, cardiac catheterization, and cardiac surgical capability — often accomplished by maternal transfer prior to delivery ("maternal transport") rather than postnatal transport of a critically ill neonate, since maternal transport is safer and allows immediate specialist evaluation at birth.
A multidisciplinary care conference — maternal-fetal medicine, pediatric cardiology, neonatology, and cardiac surgery — should occur prenatally to establish the delivery room plan, anticipated interventions (e.g., immediate PGE1, balloon atrial septostomy for TGA), and family counseling.
Family counseling should cover expected postnatal course, surgical strategy (single-stage repair versus staged palliation), anticipated hospital length of stay, and long-term prognosis, ideally with pediatric cardiology and, where relevant, cardiac surgery present.
Serial fetal echocardiography is often repeated in the third trimester for lesions at risk of evolving physiology (e.g., worsening outflow obstruction, evolving hydrops, arrhythmia) since the severity of some lesions changes over gestation.
Every prenatally suspected CHD diagnosis requires a confirmatory postnatal echocardiogram, ideally within the first 24 hours of life, both to confirm the prenatal diagnosis and to finalize the immediate management plan — prenatal imaging guides preparation but postnatal imaging remains definitive.